← Leaderboards
Ana M Navarro
University Of California San Diego
$9,864,639
Attributed
$9,864,639
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3.2M · FY2005–13$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$16,160,674 · 6
By mechanism
U54$13,254,102 · 4
U56$2,209,373 · 1
R25$697,199 · 1
Top collaborators
- Sheila E. Crowe1 shared
- Maria Elena Martinez1 shared
Most similar at University Of California San Diego
Same institution · by research overlap
- John P Pierce$34,434,149
- Gary Steven Firestein$129,601,524
- Vicky E Jones$0
- Gerry R Boss$29,163,355
- Cheryl L Rock$9,282,089
Others in their field
Top investigators on “Evaluation”
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- David Heimbrook · Leidos Biomedical Research, Inc.$564,050,020
- Lawrence Corey · Fred Hutchinson Cancer Center$559,122,174
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$489,869,793
- Jeffrey P Krischer · University Of South Florida$466,087,841
- Judith S. Currier · University Of California Los Angeles$403,175,569
Research focus
EvaluationMalignant NeoplasmsProgramsUniversitiesFacultyCollaborationsCancer CenterBaseLeadershipMalignant Neoplasm Of PancreasInstitutionGrantInterestSymposiumPharmaceutical PreparationsStructureFundingResearch InfrastructureAnticancer ResearchResourcesMeetingsDesignMinorityJoints
Grant awards (32)
Development$265,842
U54 · FY2013 · CA · contact PI
Development$965,464
U54 · FY2012 · CA · contact PI
Evaluation of Novel Sansalvamide A Derivatives as Potential Anti-Cancer Agents$276,783
U54 · FY2012 · CA · contact PI
Administration$180,343
U54 · FY2012 · CA · contact PI
Comprehensive SDSU-UCSD Cancer Center Partnership (2 of 2)$1,420,122
U54 · FY2011 · CA
Development$962,061
U54 · FY2011 · CA · contact PI
Evaluation of Novel Sansalvamide A Derivatives as Potential Anti-Cancer Agents$277,258
U54 · FY2011 · CA · contact PI
Administration$180,803
U54 · FY2011 · CA · contact PI
Comprehensive SDSU-UCSD Cancer Center Partnership (2 of 2)$1,466,347
U54 · FY2010 · CA · contact PI
Development$1,010,066
U54 · FY2010 · CA · contact PI
Evaluation of Novel Sansalvamide A Derivatives as Potential Anti-Cancer Agents$291,218
U54 · FY2010 · CA · contact PI
Comprehensive SDSU-UCSD Cancer Center Partnership (2 of 2)$216,000
U54 · FY2010 · CA · contact PI
Administration$190,063
U54 · FY2010 · CA · contact PI
Comprehensive SDSU-UCSD Cancer Center Partnership (2 of 2)$25,000
U54 · FY2010 · CA · contact PI
Comprehensive SDSU-UCSD Cancer Center Partnership (2 of 2)$1,438,166
U54 · FY2009 · CA · contact PI
Development$973,238
U54 · FY2009 · CA · contact PI
Comprehensive SDSU-UCSD Cancer Center Partnership (2 of 2)$309,000
U54 · FY2009 · CA · contact PI
Evaluation of Novel Sansalvamide A Derivatives as Potential Anti-Cancer Agents$281,227
U54 · FY2009 · CA · contact PI
Administration$183,701
U54 · FY2009 · CA · contact PI
Comprehensive SDSU-UCSD Cancer Center Partnership (2 of 2)$1,421,400
U54 · FY2008 · CA · contact PI
Development$624,895
U54 · FY2008 · CA · contact PI
Evaluation of Novel Sansalvamide A Derivatives as Potential Anti-Cancer Agents$177,052
U54 · FY2008 · CA · contact PI
Administration$118,053
U54 · FY2008 · CA · contact PI
Cooperative Planning of the SDSU/UCSD Cancer Partnership$193,125
U56 · FY2007 · CA · contact PI
Cooperative Planning of the SDSU/UCSD Cancer Partnership$434,690
U56 · FY2006 · CA · contact PI
Cooperative Planning of the SDSU/UCSD Cancer Partnership$440,800
U56 · FY2005 · CA
Cooperative Planning of the SDSU/UCSD Cancer Partnership$380,000
U56 · FY2004 · CA
Cooperative Planning of the SDSU/UCSD Cancer Partnership$379,520
U56 · FY2003 · CA
Cooperative Planning of the SDSU/UCSD Cancer Partnership$381,238
U56 · FY2002 · CA
POR LA VIDA INTERVENTION MODEL IN CANCER EDUCATION$289,651
R25 · FY2001 · CA
POR LA VIDA INTERVENTION MODEL IN CANCER EDUCATION$379,555
R25 · FY2000 · CA
POR LA VIDA INTERVENTION MODEL IN CANCER EDUCATION$27,993
R25 · FY2000 · CA